Phase 1 Prostate Neoplasm Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Breast NeoplasmsColorectal NeoplasmsProstate Neoplasm+2 more

Eli Lilly and Company421 enrolled28 locationsNCT07114601

Recruiting

Phase 1

A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer

Metastatic Castration-resistant Prostate Neoplasms

Janssen Research & Development, LLC300 enrolled15 locationsNCT05818683

Recruiting

Phase 1Phase 2

Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy

Prostate CancerProstate Neoplasm

Washington University School of Medicine36 enrolled1 locationNCT03424850